Omnicare — Q1 2015 Earnings Presentation
17 slides from Omnicare's earnings presentation, Apr 29, 2015
Slide 1: First-Quarter 2015 Financial Results Supplemental Slides
First-Quarter 2015 Financial Results Supplemental Slides
Slide 2: Forward-Looking Statements
Certain of the statements made today and listed within the following presentation slides are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, all statements regarding the intent, b
Slide 3: Table of Contents
3 Table of Contents First-Quarter 2015 Highlights……………………………………………… First-Quarter 2015 Segment Highlights………………………………….. Gross Profit & Adjusted Operating Income…………………………………. Adjusted Net Income & Cash EPS…………………………………………... Adjusted Operating Income by Segment……………………………………. Cash Flows
Slide 4: Continuing Operations First-Quarter 2015 Highlights
Continuing Operations First-Quarter 2015 Highlights Adjusted Cash-Based Earnings per Diluted Share(1) 4 Q1 2014 Q1 2015 Discontinued Operations(2) Total $1.02 $0.00 $1.02 $0.91 $0.01 $0.92 Revenue of $1,660M 5.7% increase y/y 1. Each adjusted item excludes special items and discontinued operations.
Slide 5: First-Quarter 2015 Segment Highlights
First-Quarter 2015 Segment Highlights(1) 5 Long-Term Care Group Specialty Care Group ■ 1Q15 Revenue of $1,194.5M up 0.3% from the prior year quarter - Fifth consecutive quarter of year-over-year revenue growth - Scripts per calendar day increased 1.0% from prior quarter ■ Adjusted operating income(1
Slide 6: Gross Profit & Adjusted Operating Income
Prior Year In millions, except per share data and % 1Q 2015 4Q 2014 Increase / (Decrease) 1Q 2014 Increase / (Decrease) Net sales 1,659.8$ 1,627.9$ 2.0% 1,571.0$ 5.7% Cost of sales 1,310.4 1,273.5 2.9% 1,212.6 8.1% Gross profit 349.5$ 354.4$ (1.4%) 358.5$ (2.5%) Rate 21.05% 21.77% (72 bps) 22.82% (1
Slide 7: Adjusted Net Income & Cash EPS
Adjusted Net Income & Cash EPS(1)(2) 7 1. Each amount is reported independently. The sum of the individual amounts may not equal the separately presented amounts due to rounding. 2. Each adjusted item excludes special items and discontinued operations. A reconciliation of non-GAAP information to the
Slide 8: Adjusted Operating Income by Segment
Adjusted Operating Income by Segment(1) 8 Sequential and year-over-year growth in revenue and adjusted operating income in the Long-Term Care business Specialty Care Group first-quarter adjusted operating income growth of 23% to $39M was driven by strong organic growth across all platforms and t
Slide 9: Cash Flows
Prior Year In millions, except % 1Q 2015 4Q 2014 Increase / (Decrease)(3) 1Q 2014 Increase / (Decrease)(3) Net income / (Loss) 77.4$ (6.0)$ NM 63.8$ 21.3% (Income) from discontinued operations -$ (2.7)$ 100.0% (0.1)$ 100.0% Adjustments to reconcile net income to net cash flows from operating activit
Slide 10: Cash Deployment
Cash Deployment 10 Repurchased 1.8 million shares of common stock for an aggregate amount of $125 million in 1Q15 Between dividends paid and shares repurchased, returned $146 million of operating cash flows to shareholders As of March 31, 2015, Omnicare had $140 million of share repurchase aut
Slide 11: Sequential Operating Metrics Script Data
Prior Year In thousands, except % 1Q 2015 4Q 2014 Increase / (Decrease) 1Q 2014 Increase / (Decrease) Long-Term Care Group Scripts: Generic scripts dispensed 19,997 20,204 (1.0%) 20,853 (4.1%) Branded scripts dispensed 3,828 3,895 (1.7%) 4,107 (6.8%) Over-the-counter scripts dispensed 3,194 3,256 (1
Slide 12: Full-Year 2015 Guidance
Full-Year 2015 Guidance 1. Guidance provided on February 25, 2015 2. Guidance provided on April 29, 2015 3. FY14 results exclude discontinued operations and include settlement payments of $120 million. 2015 guidance excludes the impact of settlement payments. 12 Net sales Previous Guidance(1) Adjust
Slide 13: Appendix
RNY ly, “yg; Omnicare Appendix
Slide 14: Capital Structure Initiatives Have Created More Predictable Debt Structure
Capital Structure Initiatives Have Created More Predictable Debt Structure $252M $20M $20M $20M $315M $241M $400M $300M $80M $306M $424M $0M $200M $400M $600M 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2033 2042 2044 Previous Maturity Schedule Current Maturity Schedule Composition of Debt: Co
Slide 15: Working Capital Management
Working Capital Management Five Quarter Trend(1) 15 Efficiency initiatives have driven working capital improvements 1. DOH = Ending Inventory / (Quarterly Cost of Sales / Days in Quarter); DSO = Ending Account Receivable / (Quarterly Sales / Days in Quarter). 32.9 29.5 36.2 37.5 31.9 43.3 39.2 37.3
Slide 16: Selected Branded Drug Patent Expirations
1. All generic launches are subject to change due to litigation or pediatric exclusivity. 16 2015 2016 Selected Branded Drug Patent Expirations(1) 1Q15 - Launched 2Q15 3Q15 4Q15 Androgel Clobex Spray Colcrys Focalin XR Lamictal ODT Nexium Oxycontin (Limited) Stromectol (Tab) Zyvox IV Abilify Fazaclo
Slide 17: First-Quarter 2015 Financial Results Supplemental Slides
First-Quarter 2015 Financial Results Supplemental Slides